Form 4: Viking Therapeutics CEO Brian Lian Reports Stock Transactions Following RSU Vesting
SEC Form 4 Filing
Brian Lian, President & CEO of Viking Therapeutics, reports acquisition and disposal of company stock related to performance restricted stock units (RSUs) and tax obligations.
Summary
- On July 29, 2024, Brian Lian, the President & CEO of Viking Therapeutics, acquired 41,000 shares and 163,333 shares of common stock due to the vesting of performance restricted stock units (RSUs).
- These RSUs were granted on January 4, 2021, and January 3, 2024, respectively, with 33.33% of each vesting upon achievement of a non-financial performance goal.
- On July 30, 2024, Lian sold a total of 115,859 shares in multiple transactions to satisfy tax withholding obligations related to the RSU vesting.
- The sales occurred at weighted average prices of $56.95, $57.81, and $58.78 per share.
- Following these transactions, Lian directly owns 2,354,927 shares of Viking Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the CEO's stock ownership.
Positives
- The vesting of performance-based RSUs indicates achievement of certain non-financial performance goals by the company.
Industry Context
Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company executives and directors regarding their holdings of the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased number of shares in the market, but the sales are primarily driven by tax obligations.
Key Dates
| Date | Description |
|---|---|
| January 4, 2021 | Date of grant for a performance restricted stock unit award, 33.33% of which vested on July 29, 2024. |
| January 3, 2024 | Date of grant for a performance restricted stock unit award, 33.33% of which vested on July 29, 2024. |
| July 29, 2024 | Vesting date for 33.33% of performance restricted stock units granted on January 4, 2021, and January 3, 2024. |
| July 30, 2024 | Date of stock sales to cover tax obligations related to RSU vesting. |
| July 31, 2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.